NF-κB and mucosal homeostasis

Current Topics in Microbiology and Immunology

Volumn 349, Issue , 2011, Pages 145-158

  Eckmann, Lars ^a   Neish, Andrew S ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROBIOTIC AGENT;

ACUTE DISEASE; ARTICLE; BACTERIAL GROWTH; BACTERIAL TRANSLOCATION; COMMENSAL; DOWN REGULATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOREGULATION; INTESTINE FLORA; INTESTINE INJURY; INTESTINE MUCOSA; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; HOMEOSTASIS; MICROBIOLOGY; PHYSIOLOGY; REVIEW;

MAMMALIA;

ANIMALS; HOMEOSTASIS; HUMANS; INTESTINAL MUCOSA; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84860000813     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-103     Document Type: Article

References (68)

1. Abreu MT, Fukata M, Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 174:4453-4460
2. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801 (Pubitemid 43261452)
3. Andoh A, Zhang Z, Inatomi O, et al (2005) Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129:969-984 (Pubitemid 41242688)
4. Angot A, Vergunst A, Genin S, Peeters N (2007) Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems. PLoS Pathog 3:e3
5. Arbibe L, Kim DW, Batsche E, Pedron T, Mateescu B, Muchardt C, Parsot C, Sansonetti PJ (2007) An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol 8:47-56 (Pubitemid 46242358)
6. Buchon N, Broderick NA, Chakrabarti S, Lemaitre B (2009) Invasive and indigenous microbiota impact intestinal stem cell activity through multiple pathways in Drosophila. Genes Dev 23:2333-2344
7. Burdelya LG, Krivokrysenko VI, Tallant TC et al (2008) An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320:226-230 (Pubitemid 351521417)
8. Cario E, Gerken G, Podolsky DK (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132:1359-1374 (Pubitemid 46627595)
9. Cash HL, Whitham CV, Behrendt CL, Hooper LV (2006) Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313:1126-1130 (Pubitemid 44300239)
10. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M (2003) The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 9:575-581 (Pubitemid 36597104)
11. Chiarugi P, Pani G, Giannoni E et al (2003) Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161:933-944 (Pubitemid 36718426)
12. Collier-Hyams LS, Sloane V, Batten BC, Neish AS (2005) Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J Immunol 175:4194-4198 (Pubitemid 41361952)
13. Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Bao ZQ, Chen H, Madara JL, Orth K, Neish AS (2002) Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, antiapoptotic NF-kappa B pathway. J Immunol 169:2846-2850 (Pubitemid 35013124)
14. Costello CM, Mah N, Hasler R et al (2005) Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2:e199
15. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308:1635-1638 (Pubitemid 40807514)
16. Eckmann L, Nebelsiek T, Fingerle AA et al (2008) Opposing functions of IKKbeta during acute and chronic intestinal inflammation. Proc Natl Acad Sci USA 105:15058-15063
17. Egan LJ, Eckmann L, Greten FR, Chae S, Li ZW, Myhre GM, Robine S, Karin M, Kagnoff MF (2004) IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci USA 101:2452-2457 (Pubitemid 38269332)
18. Ferencz A, Racz B, Gasz B, Kalmar-Nagy K, Horvath OP, Roth E (2006) Threshold level of NF-kB activation in small bowel ischemic preconditioning procedure. Transplant Proc 38:1800-1802 (Pubitemid 44190020)
19. Galan JE (2009) Common themes in the design and function of bacterial effectors. Cell Host Microbe 5:571-579
20. Greten FR, Arkan MC, Bollrath J et al (2007) NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130:918-931 (Pubitemid 47332565)
21. Hooper LV, Gordon JI (2001) Commensal host-bacterial relationships in the gut. Science 292:1115-1118 (Pubitemid 32440925)
22. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S (2008) Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3:352-363 (Pubitemid 351773099)
23. Iyer C, Kosters A, Sethi G, Kunnumakkara AB, Aggarwal BB, Versalovic J (2008) Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling. Cell Microbiol 10:1442-1452 (Pubitemid 351837265)
24. Jones RM, Wu H, Wentworth C, Luo L, Collier-Hyams L, Neish AS (2008) Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3:233-244 (Pubitemid 351494717)
25. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18:621-663 (Pubitemid 30365393)
26. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115:695-702 (Pubitemid 40322244)
27. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5:104-112 (Pubitemid 38081475)
28. Kelly D, Conway S, Aminov R (2005) Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 26:326-333 (Pubitemid 40732666)
29. Kim DW, Lenzen G, Page AL, Legrain P, Sansonetti PJ, Parsot C (2005) The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci USA 102:14046-14051 (Pubitemid 41377700)
30. Kumar A, Wu H, Collier-Hyams LS, Hansen JM, Li T, Yamoah K, Pan ZQ, Jones DP, Neish AS (2007) Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. Embo J 26:4457-4466 (Pubitemid 350036625)
31. Kumar A, Wu H, Collier-Hyams LS, Kwon YM, Hanson JM, Neish AS (2009) The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen speciesmediated changes in cullin-1 neddylation. J Immunol 182:538-546
32. Le Negrate G, Faustin B, Welsh K et al (2008) Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responses. J Immunol 180:5045-5056
33. Lee WJ (2008) Bacterial-modulated signaling pathways in gut homeostasis. Sci Signal 1:pe24
34. Ley RE, Peterson DA, Gordon JI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837-848 (Pubitemid 43261456)
35. Lin PW, Myers LE, Ray L et al (2009) Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med 47:1205-1211
36. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116:1107-1114 (Pubitemid 29203020)
37. McVay LD, Keilbaugh SA, Wong TM et al (2006) Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J Clin Invest 116:2914-2923 (Pubitemid 44684476)
38. Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M (2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53:821-828 (Pubitemid 38662131)
39. Moore-Olufemi SD, Kozar RA, Moore FA, Sato N, Hassoun HT, Cox CS Jr, Kone BC (2005) Ischemic preconditioning protects against gut dysfunction and mucosal injury after ischemia/reperfusion injury. Shock 23:258-263 (Pubitemid 40293827)
40. Mukherjee S, Hao YH, Orth K (2007) A newly discovered post-translational modification-the acetylation of serine and threonine residues. Trends Biochem Sci 32:210-216 (Pubitemid 46694332)
41. Neish AS (2009) Microbes in gastrointestinal health and disease. Gastroenterology 136:65-80
42. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL (2000) Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289:1560-1563
43. Nenci A, Becker C, Wullaert A et al (2007) Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446:557-561 (Pubitemid 46514732)
44. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2:998-1004 (Pubitemid 26306838)
45. Ogier-Denis E, Mkaddem SB, Vandewalle A (2008) NOX enzymes and toll-like receptor signaling. Semin Immunopathol 30:291-300
46. Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE (1999) Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 285:1920-1923
47. Pena JA, Versalovic J (2003) Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol 5:277-285 (Pubitemid 36511574)
48. Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, De Simone C, Chang EB (2004) Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127:1474-1487 (Pubitemid 39457773)
49. Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS (2005) Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 102:99-104 (Pubitemid 40094435)
50. Rafiee P, Stein DJ, Nelson VM, Otterson MF, Shaker R, Binion DG (2010) Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). Am J Physiol Gastrointest Liver Physiol 298:G167-G176
51. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229-241 (Pubitemid 38962578)
52. Rogler G, Brand K, Vogl D et al (1998) Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115:357-369 (Pubitemid 28363428)
53. Rytkonen A, Holden DW (2007) Bacterial interference of ubiquitination and deubiquitination. Cell Host Microbe 1:13-22 (Pubitemid 46506012)
54. Sansonetti PJ (2004) War and peace at mucosal surfaces. Nat Rev Immunol 4:953-964 (Pubitemid 39620070)
55. Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577-594 (Pubitemid 351173057)
56. Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42:477-484 (Pubitemid 28186562)
57. Steinbrecher KA, Harmel-Laws E, Sitcheran R, Baldwin AS (2008) Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation. J Immunol 180:2588-2599
58. Suzuki T, Yamashita K, Jomen W et al (2008) The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats. J Surg Res 149:69-75
59. Terada LS (2006) Specificity in reactive oxidant signaling: think globally, act locally. J Cell Biol 174:615-623
60. Tien MT, Girardin SE, Regnault B, Le Bourhis L, Dillies MA, Coppee JY, Bourdet-Sicard R, Sansonetti PJ, Pedron T (2006) Anti-inflammatory effect of Lactobacillus casei on Shigellainfected human intestinal epithelial cells. J Immunol 176:1228-1237 (Pubitemid 43099727)
61. Vijay-Kumar M, Aitken JD, Sanders CJ, Frias A, Sloane VM, Xu J, Neish AS, Rojas M, Gewirtz AT (2008) Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J Immunol 180:8280-8285
62. Vijay-Kumar M, Sanders CJ, Taylor RT et al (2007) Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 117:3909-3921 (Pubitemid 350224100)
63. Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, King TP, Kelly D, Gewirtz AT, Neish AS (2006) Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am J Pathol 169:1686-1700 (Pubitemid 351182000)
64. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132:562-575 (Pubitemid 46274659)
65. Zaph C, Troy AE, Taylor BC et al (2007) Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446:552-556 (Pubitemid 46514719)
66. Zeng H, Carlson AQ, Guo Y, Yu Y, Collier-Hyams LS, Madara JL, Gewirtz AT, Neish AS (2003) Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 171:3668-3674 (Pubitemid 37254570)
67. Zeng H, Wu H, Sloane V, Jones R, Yu Y, Lin P, Gewirtz AT, Neish AS (2006) Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. Am J Physiol Gastrointest Liver Physiol 290:G96-G108
68. Zou L, Attuwaybi B, Kone BC (2003) Effects of NF-kappa B inhibition on mesenteric ischemiareperfusion injury. Am J Physiol Gastrointest Liver Physiol 284:G713-G721 (Pubitemid 36343221)